Knowledge translation and molecular therapeutics

Knowledge translation and molecular therapeutics

Description

The integration of precision medicine-related findings into the clinic is essential if field is to succeed. I developed clinical practice guidelines to aid in pharmacogenomic decision making in cancer to help achieve this goal. I have also been involved in the development of a pharmacogenomics testing panel that will be available throughout Canada with the support of a $3 million grant.

Further, I am currently engaged in activities related to molecular therapeutics in Huntington disease, by refining antisense molecules to silence mutant protein by incorporating the use of population genetics data.

Avatar
Galen Wright
Research Associate